Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial

NCT00316901 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

Kidney Cancer
Melanoma (Skin)

Interventions

PROCEDURE: computed tomography
PROCEDURE: positron emission tomography
RADIATION: fludeoxyglucose F 18

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]